GEN Exclusives

More »

Feature Articles

More »
Oct 1, 2013 (Vol. 33, No. 17)

Human Disease Models Move Underwater

  • Click Image To Enlarge +
    Researchers at the University of California, Santa Barbara selected a tunicate, Botryllus schlosseri, for study because it is a simplified model for understanding allorecognition. Bodies (called zooids) form into a flower-shaped structure in the middle of the field. Each zooid is an independent, filter-feeding body, complete with a GI tract, heart, nervous system, etc. Also, the oral siphon can be seen on the periphery of each zooid. All the zooids are derived from a founder individual via a process of asexual reproduction.

    From Ilya Mechnikov discovering phagocytosis in starfish larvae to Hodgkin and Huxley defining the principles of nerve conduction in the giant axons of squid, aquatic animal models have influenced our understanding of human biology for over 100 years.

    Yet the power of these marine models extends past the realm of basic biology and into the sphere of translational medicine, offering unique versatility for pathogenic exploration that cannot be found in other animal models.

    This facet was on marked display at the “Aquatic Animal Models for Human Disease and Midwest Zebrafish” conference held at the University of Wisconsin-Milwaukee School of Freshwater Sciences in July.

    Simplicity and a diversity of tools are the prominent advantages of aquatic models of human disease, according to developmental biologist Anthony De Tomaso, Ph.D., associate professor at the University of California, Santa Barbara.

    Such is the case with his study of Botryllus schlosseri, a star-shaped invertebrate whose extracorporeal vasculature—coursing along the surface of its body—allows for direct examination of the interactions between immune cells.

    “Basically it is a simplified model for understanding self/nonself recognition or allorecognition,” said Dr. De Tomaso. “Our [human] immune cells are running around inside of our bodies, while in Botryllus, the cells are outside the body. Thus you can touch them or watch them come into contact with each other, all within two sessile cell layers.”

    Allorecognition enables genetically compatible Botryllus tunicates to form colonies, but also features in fusion-rejection pathways that functionally mimic how the human body accepts or rejects organ transplants.

    In humans, allorecognition is governed by the major histocompatibility complexes, which are the most diverse gene family in vertebrates. In contrast, histocompatibility in Botryllus is governed by single locus—fuhc—that encodes two highly polymorphic genes. Dr. De Tomaso has uncovered that these two inputs let Botryllus’ cells “integrate multiple signaling events from the cell surface and make a decision on a response.”

    These pathways have been highly conserved throughout metazoan evolution, suggesting that understanding chordate histocompatibility can provide clinically relevant information on immune processes such as tolerance and education, especially for natural killer cells, according to Dr. De Tomaso.

    Another translational feature of Botryllus involves a fierce competition between the stem cells of two tunicates fusing into a new clonal chimera. In some incidents, circulating stem cells from one animal will try to hijack the germline or somatic cells of its new partner.

    This cellular parasitism hearkens to the aggressive nature of malignant tumors and cancer stem cells.

    “The Botryllus system has a natural situation where variation in stem cell properties—growth, migration, competition—provides a definite correlation to why one stem cell population is better than the next,” said Dr. De Tomaso. “This is the other biomedical aspect of our work. Botryllus could provide clues as to why some cancer stem cells are better at migrating or self-renewing.”

  • Growing Older with Aplysia and Icefish

    Click Image To Enlarge +
    Aplysia californica is favored for neurobiological aging studies as its entire lifespan is completed within a single year and its nervous system is rather small. [University of Miami]

    While histocompatibility represents an immunological definition of self, people are most cognizant of the identity defined by their mental awareness, especially their memories. This is most pertinent in the clinical realm of Alzheimer’s disease and other forms of dementia.

    New dimensions of neurobiological aging are being revealed by research with the seaslug Aplysia californica in the laboratory of Lynne Fieber, Ph.D., associate professor of marine biology and fisheries at the University of Miami. Based across the street from the NIH/University of Miami National Resource for Aplysia Facility, Dr. Fieber’s team of marine biologists has uncovered novel insights into age-related declines in glutamate signaling.

    “We’re trying to understand the fundamental differences between sensation and motor activity,” said Dr. Fieber. “When you feel pinch or heat on the tip of your finger, how does that reflex age?”

    Over the last two decades it has become clear that changes in sensory and motor function are associated with Alzheimer’s disease, especially at early or presymptomatic stages of the condition. Reductions in glutamate levels within the nervous system are a classic hallmark of aging in both humans and Aplysia.

    Aplysia offers a great context for neurobiological aging studies as its entire lifespan is completed within a single year. In addition, its nervous system is rather small (20,000 neurons) in comparison to humans (85 billion neurons) or animal models such as mice (75 million neurons). Thus there is nearly a one-to-one correspondence between sensory neurons, motor neurons, and muscles, which provides better resolution for deciphering neural circuits and electrophysiology.

    “The organization of the nervous system is different in invertebrates compared to vertebrates. Nevertheless at a basic level, there are very conserved physiological and neurological phenomena that are present in both kinds of animals,” said Dr. Fieber, who noted that Eric Kandel’s groundbreaking research with Aplysia demonstrated how neurons are able to form and store memories.

    Dr. Fieber is capitalizing on the power and simplicity of this model to examine D-aspartate, a chemical in the nervous system that is emerging as a possible endogenous agonist for glutamate receptors. She began the project a few years ago in collaboration with neurobiologist Antimo D’Aniello, Ph.D., of the Stazione Zoologica (Naples, Italy). Dr. D’Aniello has found that free D-aspartate in the brains of humans radically changes with age.

    While D-aspartate can substitute for glutamate at certain synapses, it appears that the compound also activates an unidentified receptor in mammals and Aplysia. Dr. Fieber is now conducting a search for this unidentified glutamate receptor.

  • Click Image To Enlarge +
    Ancient-lineage Antarctic icefish, which have modified how their genes for bone mineralization are expressed, are helping scientists at the University of Oregon isolate regulatory gene regions that are responsible for maintaining bone density.

    Cognitive prowess is not the only line of aging research to benefit from aquatic models. John Postlethwait, Ph.D., professor of biology at the University of Oregon, is studying ancient Antarctic icefish to find clues as to why bones lose mineral density over the course of lifetime, a condition known as osteopenia.

    Although less severe than osteoporosis, this bone condition is nearly three times as prevalent in people over the age of 50. Nearly four out of five cases are associated with acute pain, and 25% of women with osteopenia will sustain a vertebral compression fracture.

    Instead of occurring over developmental time—80–90 years for humans—bone density was lost in Notothenioid fish lineages over the course of 10 million years. As the waters cooled along the coasts of Antartica, the rich fauna near the shore of the island continent began to die off and were replaced by the bottom-feeding—benthic—Notothenioids. However these fish lacked a swim bladder, a lung-like sac that allows fish to regulate their buoyancy. So to complete their upward migration, Notothenioid species either acquired the ability to produce more lipids or lost mass from their bones, which are the most dense organs in the body.

    How does evolutionary progression with icefish relate to age-related osteopenia? More buoyant icefish lineages retained their genes for bone mineralization, but changed how they regulate these genes, which is a scenario that mimics bone density loss in humans.

    “The two processes, in humans and icefish, are the same,” said Dr. Postlethwait. “We know that most people don’t have mutations that completely block bone mineralization. What they have are mutations that dysregulate the control of bone mineralization genes.”

    By comparing the genetic profiles of poorly and robustly mineralized fish, Dr. Postlethwait’s team hopes to isolate regulatory gene regions—enhancers, promoters, and repressors—that are responsible for maintaining bone density.

    These findings could be used to improve the resolution of genome-wide association studies (GWAS) of skeletal profiles, which have identified about 60 loci of previously unknown function.

    “The problem is many or most of these identified genetic loci are out in the middle of nowhere. They are near genes but not in coding regions,” said Dr. Postlethwait. “If we can identify specific regulatory elements that are responsible for bone mineralization dissonance in the Antarctic icefish, we can then search for similar elements in humans.”



Related content

Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?